Mutations in the human NAGLU gene causing MPS IIIB have a clearly understood pathological mechanism; they reduce a lysosomal enzyme activity required in the degradation of heparan sulfate [38]. This evidence concerns the gene NAGLU and mucopolysaccharidosis type 3B.